| Bengoa Eye Care | |
|
1050 Hanson St, Winnemucca, NV 89445-2774 | |
| (775) 625-3937 | |
| (775) 625-3938 |
| Full Name | Bengoa Eye Care |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 1050 Hanson St, Winnemucca, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073865630 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 497 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bengoa Eye Care 1050 Hanson St, Winnemucca, NV 89445-2774 Ph: (775) 625-3937 | Bengoa Eye Care 1050 Hanson St, Winnemucca, NV 89445-2774 Ph: (775) 625-3937 |
News Archive
Getting a flu shot this fall? Canadians scientists have found that focusing on a pretty image could alleviate the sting of that vaccine. According to a new Universit- de Montr-al study, published in the latest edition of the Proceedings of the National Academy of Sciences (PNAS), negative and positive emotions have a direct impact on pain.
One of the most common and serious infectious diseases, Hepatitis B, is to be targeted in a new collaborative venture between the internationally-renowned translational research institute, Institut Pasteur Korea (IP-K), and the Korean arm of the leading global healthcare company, Sanofi-Aventis Korea. The goal is to develop and validate a high throughput assay to screen IP-K's chemical libraries for novel compounds that can be developed as new drugs.
Kite Pharma, Inc., a clinical-stage biotechnology company focused on developing engineered autologous T cell therapy (eACT) products for cancer, today announced that the U.S. Food and Drug Administration Office of Orphan Products Development granted orphan drug designation for the Company's lead investigational therapy, an autologous engineered T cell product that targets CD19 expression on B cell malignancies, for the treatment of diffuse large B cell lymphoma (DLBCL).
Although it is already one of medicine's most successful transplant procedures, doctors continue to seek ways to improve corneal transplants. Now, for the first time, a team of German and British researchers have confirmed that failure and rejection of transplanted corneas are more likely in patients whose eyes exhibit abnormal vessel growth, called corneal neovascularization, prior to surgery.
› Verified 6 days ago
Northern Nevada Eyecare Ltd Optometrist Medicare: Not Enrolled in Medicare Practice Location: 50 E Haskell St Suite A, Winnemucca, NV 89445 Phone: 775-623-5211 Fax: 775-623-5236 | |
Vision Consultants Optometrist Medicare: Not Enrolled in Medicare Practice Location: 118 E Haskell St, Winnemucca, NV 89445 Phone: 775-375-8869 | |
Northern Nevada Eyecare Ltd Optometrist Medicare: Not Enrolled in Medicare Practice Location: 50 E Haskell St., Suite A, Winnemucca, NV 89445 Phone: 775-623-5211 Fax: 775-623-5236 | |
Amy E Sullivan, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1050 Hanson St, Winnemucca, NV 89445 Phone: 756-253-9377 Fax: 775-625-3938 | |
Amy E Sullivan Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1050 Hanson St, Winnemucca, NV 89445 Phone: 775-625-3937 Fax: 775-625-3938 | |
B. Michael Southam, Od, Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 625 Sheehan St Apt E, Winnemucca, NV 89445 Phone: 775-625-4733 Fax: 775-625-4735 |